LAHORE, Nov 27: The Pakistan Pharmaceutical Manufacturers Association (PPMA) has condemned the criminal action against the pharma company which manufactured cough syrup saying that the firm had suffered an irreparable loss.

At a press conference here on Tuesday, PPMA North Zone Chairman Saleem Iqbal said the criminal action against the pharma company before completion of the inquiry had damaged its repute.

He said the authorities had taken steps in haste and sealed the factory besides harassing its owner which was a condemnable act.

Mr Saleem said the neighboring country (India) had been raising such incidents at international forums to defame Pakistan. The government should realize the situation and devise a mechanism of investigation keeping in view the interests of the pharmaceutical industries too.

“The firm has been manufacturing the syrup since 1978 and enjoys good repute in the industry for manufacturing quality medicines”, he said.

The PPMA chairman has asked the government to withdraw all actions against the firm and its owner till the completion of inquiries.

Editorial

Ominous demands
Updated 18 May, 2024

Ominous demands

The federal government needs to boost its revenues to reduce future borrowing and pay back its existing debt.
Property leaks
18 May, 2024

Property leaks

THE leaked Dubai property data reported on by media organisations around the world earlier this week seems to have...
Heat warnings
18 May, 2024

Heat warnings

STARTING next week, the country must brace for brutal heatwaves. The NDMA warns of severe conditions with...
Dangerous law
Updated 17 May, 2024

Dangerous law

It must remember that the same law can be weaponised against it one day, just as Peca was when the PTI took power.
Uncalled for pressure
17 May, 2024

Uncalled for pressure

THE recent press conferences by Senators Faisal Vawda and Talal Chaudhry, where they demanded evidence from judges...
KP tussle
17 May, 2024

KP tussle

THE growing war of words between KP Chief Minister Ali Amin Gandapur and Governor Faisal Karim Kundi is affecting...